Dvorak J, Graf-Baumann T, D'Hooghe M, Kirkendall D, Taennler H, Saugy M
FIFA Medical Assessment and Research Centre, and Department of Neurology, Schulthess Clinic, Zurich, Switzerland.
Br J Sports Med. 2006 Jul;40 Suppl 1(Suppl 1):i3-i12. doi: 10.1136/bjsm.2006.027383.
FIFA's anti-doping strategy relies on education and prevention. A worldwide network of physicians guarantees doping control procedures that are straightforward and leave no place for cheating. FIFA actively acknowledges its responsibility to protect players from harm and ensure equal chances for all competitors by stringent doping control regulations, data collection of positive samples, support of research, and collaboration with other organisations. This article aims to outline FIFA's approach to doping in football.
Description of FIFA's doping control regulations and procedures, statistical analysis of FIFA database on doping control, and comparison with data obtained by WADA accredited laboratories as for 2004.
Data on positive doping samples per substance and confederation/nation documented at the FIFA medical office from 1994 to 2005 are provided. According to the FIFA database, the incidence of positive cases over the past 11 years was 0.12%, with about 0.42% in 2004 (based on the assumption of 20,750 samples per year) and 0.37% in 2005. Especially important in this regard is the extremely low incidence of the true performance enhancing drugs such as anabolic steroids and stimulants. However, there is a need for more consistent data collection and cross checks among international anti-doping agencies as well as for further studies on specific substances, methods, and procedures. With regard to general health impairments in players, FIFA suggests that principles of occupational medicine should be considered and treatment with banned substances for purely medical reasons should be permitted to enable players to carry out their profession. At the same time, a firm stand has to be taken against suppression of symptoms by medication with the aim of meeting the ever increasing demands on football players.
Incidence of doping in football seems to be low, but much closer collaboration and further investigation is needed with regard to banned substances, detection methods, and data collection worldwide.
国际足联的反兴奋剂策略依赖于教育与预防。一个遍布全球的医生网络确保了兴奋剂检测程序的直接性,杜绝作弊行为。国际足联积极承担起责任,通过严格的兴奋剂检测规定、阳性样本数据收集、研究支持以及与其他组织的合作,保护球员免受伤害,并确保所有参赛者拥有平等机会。本文旨在概述国际足联在足球领域的反兴奋剂方法。
描述国际足联的兴奋剂检测规定和程序,对国际足联兴奋剂检测数据库进行统计分析,并与世界反兴奋剂机构认可实验室在2004年获得的数据进行比较。
提供了1994年至2005年国际足联医务室记录的每种物质以及各联合会/国家的阳性兴奋剂样本数据。根据国际足联数据库,过去11年阳性案例的发生率为0.12%,2004年约为0.42%(基于每年20,750个样本的假设),2005年为0.37%。在这方面特别重要的是,合成代谢类固醇和兴奋剂等真正提高成绩的药物的发生率极低。然而,国际反兴奋剂机构之间需要更一致的数据收集和交叉核对,以及对特定物质、方法和程序进行进一步研究。关于球员的一般健康损害,国际足联建议应考虑职业医学原则,并且应允许出于纯粹医疗原因使用禁用物质,以使球员能够从事其职业。与此同时,必须坚决反对为满足对足球运动员日益增长的要求而使用药物掩盖症状的行为。
足球领域的兴奋剂发生率似乎较低,但在全球范围内,在禁用物质、检测方法和数据收集方面需要更紧密的合作和进一步调查。